Clinical Trials Logo

Lymphedema clinical trials

View clinical trials related to Lymphedema.

Filter by:

NCT ID: NCT02476357 Completed - Lymphoedema Clinical Trials

A Study for Lymphocele and Lymphorrhea Control Following Inguinal and Axillary Radical Lymph Node Dissection

Start date: January 2009
Phase: N/A
Study type: Interventional

Patients undergoing groin or axillary Radical lymph node dissection (RLND) or completion lymph node dissection (CLND, after positive sentinel lymph node biopsy (SLNB) for melanoma or breast cancer were randomized in a controlled trial for surgical dissection technique. Harmonic scalpel dissection were compared with classic dissection in term of lymphocoele and oedema.

NCT ID: NCT02462226 Completed - Breast Cancer Clinical Trials

Enhancing Management of Chronic Pain and Symptoms Among Women Treated for Breast Cancer (Lymph-Flow)

Lymph-Flow
Start date: May 1, 2015
Phase: N/A
Study type: Interventional

The purpose of this research study is to conduct a randomized clinical trial to evaluate the efficacy of the web-based The-Optimal-Lymph-Flow ™ system for managing chronic pain and symptoms related to lymphedema focusing on primary outcomes of pain reduction, secondary outcomes of symptom relief, limb volume difference by infra-red perometer, body mass index, quality of life related to pain. Recruitment includes 120 patients who will be randomized according to pain/aching/soreness, and tenderness. Participants in the intervention group will be provided the web-based The-Optimal-Lymph-Flow ™ intervention and encourage to access and learn about the program during the 1-4 weeks of the study. Participants in the control group will receive the web-based arm precaution program. All the participants will have monthly online assessment of pain and symptoms at 4 and 8 weeks post-intervention as well as two in-person research visits, that is, prior to intervention and 12 weeks post-intervention.

NCT ID: NCT02412241 Completed - Lymphedema Clinical Trials

Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients

Start date: June 2015
Phase: N/A
Study type: Interventional

This four-year, prospective, longitudinal study will evaluate and validate a patient-reported outcome measure, clinician-reported outcome measures, and imaging techniques in assessing characteristics, trajectory, and progression of lymphedema and fibrosis (LEF) in oral cavity and oropharyngeal cancer patients. This clinical trial studies patient-and-clinician-reported measures as well as standard imaging methods to see how accurate they are in identifying and evaluating lymphedema (swelling) or fibrosis (tough or tight tissue) in the head and neck region of patients receiving treatment for newly diagnosed stage II-IV oral cavity or oropharyngeal cancer. Lymphedema and fibrosis (LEF) can lead to physical symptoms, such as trouble swallowing and chewing, as well as psychological and emotional symptoms, such as negative body image and avoiding social interactions. Finding an accurate test to identify and evaluate LEF may allow doctors to treat LEF more quickly and control symptoms more effectively, and thus provide patients with a better quality of life.

NCT ID: NCT02375945 Completed - Lymphedema Clinical Trials

Comparison Between a Non-elastic Falcro Device and Current Method After Total Knee Arthroplasty

Start date: March 2015
Phase: Phase 4
Study type: Interventional

Swelling is a common problem after knee arthroplasty often leading to delayed wound healing, lasting functional impairment and hematoma. Due to this complications, sometimes the risk for deep venous thrombosis is raised. This study investigates a new self adjustable device to reduce swelling more effective postoperatively. The investigators compare the new device to the current general practice by using a standard class 1 elastic stocking

NCT ID: NCT02369679 Completed - Lymphedema Clinical Trials

Effectiveness of Two Compression Methods in the Treatment of Upper Limb Lymphedema

Start date: October 13, 2014
Phase: N/A
Study type: Interventional

Treatment of lymphedema is based on a combined program called complex decongestive therapy. The components of the complex decongestive therapy are skin care, kinesiotherapy, manual lymphatic drainage and compression. The compression with multilayer bandage has proved to be the most effective of these therapies when analyzed separately.The multilayer bandage produces a gradient compression on the limb where distal pressure is higher than proximal pressure. Several materials are needed for the multilayer bandage, including tubular bandage lining, digit bandages, foam under-cast padding and multiple layers of short-stretch bandages to cover the entire limb. The Precast Adjustable Compression Wrap fits each patient through a Velcro system. The aim is to compare the effectiveness of a precast adjustable compression wrap (Circaid) with the multilayer compression bandages in the treatment of the upper limb lymphedema.

NCT ID: NCT02352623 Completed - Depression Clinical Trials

Quality of Life and Surgical Late Effects of Melanoma Treatment

Start date: February 2015
Phase: N/A
Study type: Observational

Health-related Quality of life in Danish stage IB-III cutaneous melanoma patients.

NCT ID: NCT02308488 Completed - Lymphedema Clinical Trials

Study of Prone Accelerated Breast And Nodal IMRT

Start date: September 2009
Phase: N/A
Study type: Interventional

Following consent, patients will receive 15 fractions of radiotherapy to the affected breast and to Axillary level III and SCV (Supra-Clavicular) lymph nodes, defined by CT imaging obtained in a prone position using IMRT(intensity modulation radiation therapy ) technique: one fraction daily for 5 days/week for 3 consecutive weeks. Patients will be seen for follow-up at 45-60 days from first radiotherapy treatment, and then yearly. Patients will be assessed for Lymphedema at baseline, end of treatment, and at yearly intervals after completion of radiotherapy. All patients will be followed for toxicity and outcome (local and systemic recurrence, survival). In addition, patients will complete a self-assessment of QOL at baseline, week 3, day 45-60 and 2-yr follow-ups.

NCT ID: NCT02257970 Completed - Lymphedema Clinical Trials

Lymphedema Study for Arm or Leg Lymphedema

Start date: March 2009
Phase: Phase 4
Study type: Interventional

This study compares the effectiveness of a study drug versus placebo in the treatment of lymphedema.

NCT ID: NCT02253186 Completed - Lymphedema Clinical Trials

Clinical Study to Assess Safety and Efficacy of a New Armsleeve in the Management of Arm Lymphoedema

MARILYN
Start date: September 2014
Phase: N/A
Study type: Interventional

The objective of the study is to assess the effect of a new Armsleeve, worn during the night during maintenance phase of upper limb lymphoedema treatment in combination with Day-time usual lymphology hosiery.

NCT ID: NCT02250898 Completed - Pain Clinical Trials

Massage for Post Breast Surgery

Start date: September 2014
Phase: N/A
Study type: Interventional

The aims of this study are to determine the effectiveness of myofascial massage specific to the breast/chest/shoulder area in reducing self-reported pain and increasing mobility among patients who have undergone a mastectomy or other breast surgery compared to a control group receiving global relaxation massages.